GLUT1 deficiency syndrome: genes and variants
Explore variant evidence for GLUT1 deficiency syndrome across 1 analyzed protein (SLC2A1). Linked ClinVar records include 53 pathogenic or likely pathogenic variants, 194 variants of uncertain significance and 32 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to GLUT1 deficiency syndrome
SLC2A1: Solute carrier family 2, facilitated glucose transporter member 1
It provides basal glucose uptake in many tissues and is the principal route for glucose entry across the blood-brain barrier. Haploinsufficiency causes GLUT1 deficiency syndrome with epilepsy, developmental impairment, and movement disorders from inadequate brain glucose delivery.
53 ClinVar pathogenic / likely pathogenic and 226 uncertain variants in SLC2A1 have source records linked to GLUT1 deficiency syndrome. Association strength is not clinical gene validity.
Where GLUT1 deficiency syndrome variants cluster
- SLC2A1 Transmembrane (positions 121–144): 9 of 51 ClinVar pathogenic / likely pathogenic variants, 3.6× more than its size predicts (a length-based count, not a validated hotspot).
- SLC2A1 Cytoplasmic (positions 329–334): 4 of 51 ClinVar pathogenic / likely pathogenic variants, 6.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to GLUT1 deficiency syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC2A1 R126H | 126 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 G130S | 130 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R153C | 153 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R400L | 400 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R153H | 153 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R153S | 153 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R212C | 212 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R212H | 212 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 E329K | 329 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 M420T | 420 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 V140M | 140 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 S324L | 324 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 N34D | 34 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC2A1 P211S | 211 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 T295M | 295 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC2A1 G419D | 419 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 F422L | 422 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 M96V | 96 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 L215F | 215 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R232C | 232 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 M1T | 1 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 G17R | 17 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R93W | 93 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R333W | 333 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 V165I | 165 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 G130A | 130 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 G130C | 130 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 S294P | 294 | Extracellular | Pathogenic / likely pathogenic (★) |
| SLC2A1 S294A | 294 | Extracellular | Pathogenic / likely pathogenic (★) |
| SLC2A1 E329Q | 329 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A1 R400S | 400 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A1 C133R | 133 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 V140L | 140 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 Y293S | 293 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 V328L | 328 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 G332D | 332 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A1 A403V | 403 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 M420V | 420 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 M1L | 1 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A1 F72L | 72 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 G76V | 76 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 G134C | 134 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 S148L | 148 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A1 M180K | 180 | Extracellular | Pathogenic / likely pathogenic (★) |
| SLC2A1 L228P | 228 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A1 E243V | 243 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A1 L278P | 278 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 G314D | 314 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 N317T | 317 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 M351R | 351 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 I372N | 372 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 I386M | 386 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 R126L | 126 | Transmembrane | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in GLUT1 deficiency syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SLC2A1 Y293H | 293 | Transmembrane | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; Y293S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
| SLC2A1 M96T | 96 | Transmembrane | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; M96V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.89 |
| SLC2A1 R93Q | 93 | Transmembrane | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R93W at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.704 |
| SLC2A1 G332R | 332 | Cytoplasmic | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; G332D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| SLC2A1 G332S | 332 | Cytoplasmic | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; G332D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91 |
| SLC2A1 P211L | 211 | Cytoplasmic | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; P211S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| SLC2A1 S294C | 294 | Extracellular | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; S294P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.96 |
Same protein, different disease
- Encephalopathy due to GLUT1 deficiency also has ClinVar records linked to SLC2A1 variants; they fall in the same places as the GLUT1 deficiency syndrome variants (32 pathogenic / likely pathogenic).
- Paroxysmal exertion-induced dyskinesia also has ClinVar records linked to SLC2A1 variants; they fall partly in the same places as the GLUT1 deficiency syndrome variants (18 pathogenic / likely pathogenic).
- Hereditary cryohydrocytosis with reduced stomatin also has ClinVar records linked to SLC2A1 variants; they fall mostly in different places as the GLUT1 deficiency syndrome variants (5 pathogenic / likely pathogenic).
- Idiopathic generalized epilepsy also has ClinVar records linked to SLC2A1 variants; they fall mostly in different places as the GLUT1 deficiency syndrome variants (4 pathogenic / likely pathogenic).
Diseases related to GLUT1 deficiency syndrome
- Idiopathic generalized epilepsy, also linked to SLC2A1
- Encephalopathy due to GLUT1 deficiency, also linked to SLC2A1
- Paroxysmal exertion-induced dyskinesia, also linked to SLC2A1
- Rolandic epilepsy, also linked to SLC2A1
- Developmental disorder, also linked to SLC2A1
- Hereditary cryohydrocytosis with reduced stomatin, also linked to SLC2A1
Frequently asked questions
Which genes have records linked to GLUT1 deficiency syndrome?
This view contains 1 analyzed proteins: SLC2A1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 53 pathogenic or likely pathogenic variants, 194 variants of uncertain significance and 32 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 7 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 307 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center